Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Bartoli

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Cardiovascular Drugs and Therapy|July 17, 2024
Immunotherapy in the Context of Aortic Valve DiseasesFrancesca Bartoli-Leonard, Tim Pennel, Massimo Caputo
Cardiovascular Research|August 25, 2021
Innate and adaptive immunity: the understudied driving force of heart valve diseaseFrancesca Bartoli-Leonard, Jonas Zimmer, Elena Aikawa
Immunological Reviews|September 12, 2022
Small particles with large impact: Insights into the unresolved roles of innate immunity in extracellular vesicle-mediated cardiovascular calcificationMandy E Turner, Francesca Bartoli-Leonard, Elena Aikawa
Translational Pediatrics|September 11, 2023
Graft rejection in paediatric congenital heart diseaseAmy G Harris, Dominga Iacobazzi, Massimo Caputo, et al.
Expert Review of Clinical Immunology|June 22, 2018
Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018Francesca Bartoli, Sangmee Bae, Laura Cometi, et al.
Frontiers in Cardiovascular Medicine|January 9, 2019
The Interplay of SIRT1 and Wnt Signaling in Vascular CalcificationFrancesca Bartoli-Leonard, Fiona L Wilkinson, Alex W W Langford-Smith, et al.
Clinical and Experimental Rheumatology|December 3, 2016
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment optionsMicaela Fredi, Francesca Bartoli, Ilaria Cavazzana, et al.
Clinical and Experimental Rheumatology|June 14, 2012
CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatmentFrancesca Bandinelli, Angela Del Rosso, Armando Gabrielli, et al.
Cardiovascular Research|May 14, 2020
Loss of SIRT1 in diabetes accelerates DNA damage-induced vascular calcificationFrancesca Bartoli-Leonard, Fiona L Wilkinson, Andrew Schiro, et al.
Clinical Rheumatology|June 10, 2020
Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseasesCosimo Bruni, Roberta Bitti, Francesca Nacci, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Cardiovascular Drugs and Therapy|July 17, 2024
Immunotherapy in the Context of Aortic Valve DiseasesFrancesca Bartoli-Leonard, Tim Pennel, Massimo Caputo
Cardiovascular Research|August 25, 2021
Innate and adaptive immunity: the understudied driving force of heart valve diseaseFrancesca Bartoli-Leonard, Jonas Zimmer, Elena Aikawa
Immunological Reviews|September 12, 2022
Small particles with large impact: Insights into the unresolved roles of innate immunity in extracellular vesicle-mediated cardiovascular calcificationMandy E Turner, Francesca Bartoli-Leonard, Elena Aikawa
Translational Pediatrics|September 11, 2023
Graft rejection in paediatric congenital heart diseaseAmy G Harris, Dominga Iacobazzi, Massimo Caputo, et al.
Expert Review of Clinical Immunology|June 22, 2018
Sirukumab for the treatment of rheumatoid arthritis: update on sirukumab, 2018Francesca Bartoli, Sangmee Bae, Laura Cometi, et al.
Frontiers in Cardiovascular Medicine|January 9, 2019
The Interplay of SIRT1 and Wnt Signaling in Vascular CalcificationFrancesca Bartoli-Leonard, Fiona L Wilkinson, Alex W W Langford-Smith, et al.
Clinical and Experimental Rheumatology|December 3, 2016
Calcinosis in poly-dermatomyositis: clinical and laboratory predictors and treatment optionsMicaela Fredi, Francesca Bartoli, Ilaria Cavazzana, et al.
Clinical and Experimental Rheumatology|June 14, 2012
CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatmentFrancesca Bandinelli, Angela Del Rosso, Armando Gabrielli, et al.
Cardiovascular Research|May 14, 2020
Loss of SIRT1 in diabetes accelerates DNA damage-induced vascular calcificationFrancesca Bartoli-Leonard, Fiona L Wilkinson, Andrew Schiro, et al.
Clinical Rheumatology|June 10, 2020
Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseasesCosimo Bruni, Roberta Bitti, Francesca Nacci, et al.
Pageof 5